CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

HUMAHumacyte, Inc.

NASDAQ · Biological Products, (No Diagnostic Substances)
Last close $0.52 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBiological Products, (No Diagnostic Substances)
Market cap$143.82M
RECENT INSIDER TRADES
  • 2026-09-15 · Jones Keith Anthony (Director) · BUY
  • 2026-08-21 · Jones Keith Anthony (Director) · BUY
  • 2026-08-19 · Jones Keith Anthony (Director) · BUY
  • 2026-05-20 · Sebelius Kathleen (Director) · BUY
  • 2026-05-20 · Sander Dale A. (CFO and Chief Corp. Dev. Off) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders179
Shares held89,859,667
Value$100.15M
Percent of shares outstanding32.35%
As of quarter end2026-06-30
RECENT CONGRESSIONAL TRADES
  • 2024-05-03 · Thomas H Tuberville · SELL · $15,001 - $50,000
  • 2024-05-03 · Thomas H Tuberville · SELL · $1,001 - $15,000
  • 2024-04-30 · Thomas H Tuberville · SELL · $50,001 - $100,000
  • 2024-03-21 · Tommy Tuberville · BUY · $1,001 - $15,000
  • 2024-03-21 · Tommy Tuberville · BUY · $15,001 - $50,000
RECENT NEWS
  • Humacyte appoints Scott Coward and Paul Kuznik to Board of Directors
  • Humacyte presents dialysis strategy at H.C. Wainwright conference
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Humacyte, Inc. (HUMA) · Stock Price, Insider Trades, Congress Trades · CatalystPit